Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.

Sen. Rand Paul Talks US Debt, ICE, Future of DHS
12:21

Uber and Zoox CEOs Talk Robotaxi Partnership
08:35

Former St Louis Fed President Jim Bullard Talks Warsh's Nomination Process
05:53